# Prophylactic vs Therapeutic Anticoagulation in Symptomatic Isolated Distal Deep Vein Thrombosis

> **NCT04967573** · PHASE3 · UNKNOWN · sponsor: **Shanghai Zhongshan Hospital** · enrollment: 480 (estimated)

## Conditions studied

- Venous Thrombosis

## Interventions

- **DRUG:** Rivaroxaban

## Key facts

- **NCT ID:** NCT04967573
- **Lead sponsor:** Shanghai Zhongshan Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-08-01
- **Primary completion:** 2023-06-30
- **Final completion:** 2023-12-31
- **Target enrollment:** 480 (ESTIMATED)
- **Last updated:** 2022-02-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04967573

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04967573, "Prophylactic vs Therapeutic Anticoagulation in Symptomatic Isolated Distal Deep Vein Thrombosis". Retrieved via AI Analytics 2026-09-24 from https://api.ai-analytics.org/clinical/NCT04967573. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*